Extensions for Using Data Elements from FHIR DSTU2 in FHIR R4B - Downloaded Version null See the Directory of published versions
| Official URL: http://hl7.org/fhir/uv/xver/ValueSet/R2-v3-VaccineManufacturer-for-R4B | Version: 0.1.0 | |||
| Standards status: Trial-use | Maturity Level: 0 | Computable Name: R2V3VaccineManufacturerForR4B | ||
This cross-version ValueSet represents content from http://hl7.org/fhir/ValueSet/v3-VaccineManufacturer|2015-07-31 for use in FHIR R4B.
This value set is part of the cross-version definitions generated to enable use of the
value set http://hl7.org/fhir/ValueSet/v3-VaccineManufacturer|2015-07-31 as defined in FHIR DSTU2
in FHIR R4B.
The source value set is bound to the following FHIR DSTU2 elements:
Across FHIR versions, the value set has been mapped as:
http://hl7.org/fhir/ValueSet/v3-VaccineManufacturer|2015-07-31http://hl7.org/fhir/ValueSet/v3-VaccineManufacturer|2016-11-11http://terminology.hl7.org/ValueSet/v3-VaccineManufacturer|2018-08-12Note that all concepts are included in this cross-version definition because no concepts have compatible representations
Following are the generation technical comments:
All concepts in the comparison are listed as identical.
The source and target value sets have the same number of active concepts (40).
All concepts in the comparison are listed as identical.
The source and target value sets have the same number of active concepts (40).
FHIR ValueSet http://hl7.org/fhir/ValueSet/v3-VaccineManufacturer|2015-07-31, defined in FHIR DSTU2 does not have any mapping to FHIR R4B
References
This value set is not used here; it may be used elsewhere (e.g. specifications and/or implementations that use this content)
http://hl7.org/fhir/v3/VaccineManufacturer version 📍1.0.2| Code | Display | Definition |
| AB | Abbott Laboratories (includes Ross Products Division) | Abbott Laboratories (includes Ross Products Division) |
| AD | Adams Laboratories | Adams Laboratories |
| ALP | Alpha Therapeutic Corporation | Alpha Therapeutic Corporation |
| AR | Armour [Inactive - use CEN] | Armour [Inactive-use CEN] |
| AVI | Aviron | Aviron |
| BA | Baxter Healthcare Corporation | Baxter Healthcare Corporation |
| BAY | Bayer Corporation (includes Miles, Inc. and Cutter Laboratories) | Bayer Corporation (includes Miles, Inc. and Cutter Laboratories) |
| BP | Berna Products [Inactive - use BPC] | Berna Products [Inactive-use BPC] |
| BPC | Berna Products Corporation (includes Swiss Serum and Vaccine Institute Berne) | Berna Products Corporation (includes Swiss Serum and Vaccine Institute Berne) |
| CEN | Centeon L.L.C. (includes Armour Pharmaceutical Company) | Centeon L.L.C. (includes Armour Pharmaceutical Company) |
| CHI | Chiron Corporation | Chiron Corporation |
| CON | Connaught [Inactive - use PMC] | Connaught [Inactive-use PMC] |
| EVN | Evans Medical Limited (an affiliate of Medeva Pharmaceuticals, Inc.) | Evans Medical Limited (an affiliate of Medeva Pharmaceuticals, Inc.) |
| GRE | Greer Laboratories, Inc. | Greer Laboratories, Inc. |
| IAG | Immuno International AG | Immuno International AG |
| IM | Merieux [Inactive - use PMC] | Merieux [Inactive-use PMC] |
| IUS | Immuno-U.S., Inc. | Immuno-U.S., Inc. |
| JPN | The Research Foundation for Microbial Diseases of Osaka University (BIKEN) | The Research Foundation for Microbial Diseases of Osaka University (BIKEN) |
| KGC | Korea Green Cross Corporation | Korea Green Cross Corporation |
| LED | Lederle [Inactive - use WAL] | Lederle [Inactive-use WAL] |
| MA | Massachusetts Public Health Biologic Laboratories | Massachusetts Public Health Biologic Laboratories |
| MED | MedImmune, Inc. | MedImmune, Inc. |
| MIL | Miles [Inactive - use BAY] | Miles [Inactive-use BAY] |
| MIP | Bioport Corporation (formerly Michigan Biologic Products Institute) | Bioport Corporation (formerly Michigan Biologic Products Institute) |
| MSD | Merck and Co., Inc. | Merck & Co., Inc. |
| NAB | NABI (formerly North American Biologicals, Inc.) | NABI (formerly North American Biologicals, Inc.) |
| NAV | North American Vaccine, Inc. | North American Vaccine, Inc. |
| NOV | Novartis Pharmaceutical Corporation (includes Ciba-Geigy Limited and Sandoz Limited) | Novartis Pharmaceutical Corporation (includes Ciba-Geigy Limited and Sandoz Limited) |
| NYB | New York Blood Center | New York Blood Center |
| ORT | Ortho Diagnostic Systems, Inc. | Ortho Diagnostic Systems, Inc. |
| OTC | Organon Teknika Corporation | Organon Teknika Corporation |
| PD | Parkedale Pharmaceuticals (formerly Parke-Davis) | Parkedale Pharmaceuticals (formerly Parke-Davis) |
| PMC | Aventis Pasteur Inc. (formerly Pasteur Merieux Connaught; includes Connaught Laboratories and Pasteur Merieux) | Aventis Pasteur Inc. (formerly Pasteur Merieux Connaught; includes Connaught Laboratories and Pasteur Merieux) |
| PRX | Praxis Biologics [Inactive - use WAL] | Praxis Biologics [Inactive-use WAL] |
| SCL | Sclavo, Inc. | Sclavo, Inc. |
| SI | Swiss Serum and Vaccine Inst. [Inactive - use BPC] | Swiss Serum and Vaccine Inst. [Inactive-use BPC] |
| SKB | SmithKline Beecham | SmithKline Beecham |
| USA | United States Army Medical Research and Materiel Command | United States Army Medical Research and Materiel Command |
| WA | Wyeth-Ayerst [Inactive - use WAL] | Wyeth-Ayerst [Inactive-use WAL] |
| WAL | Wyeth-Ayerst (includes Wyeth-Lederle Vaccines and Pediatrics, Wyeth Laboratories, Lederle Laboratories, and Praxis Biologics) | Wyeth-Ayerst (includes Wyeth-Lederle Vaccines and Pediatrics, Wyeth Laboratories, Lederle Laboratories, and Praxis Biologics) |
This value set expansion contains 40 concepts.
| System | Version | Code | Display | Definition | JSON | XML |
http://hl7.org/fhir/v3/VaccineManufacturer | 1.0.2 | AB | Abbott Laboratories (includes Ross Products Division) | Abbott Laboratories (includes Ross Products Division) | ||
http://hl7.org/fhir/v3/VaccineManufacturer | 1.0.2 | AD | Adams Laboratories | Adams Laboratories | ||
http://hl7.org/fhir/v3/VaccineManufacturer | 1.0.2 | ALP | Alpha Therapeutic Corporation | Alpha Therapeutic Corporation | ||
http://hl7.org/fhir/v3/VaccineManufacturer | 1.0.2 | AR | Armour [Inactive - use CEN] | Armour [Inactive-use CEN] | ||
http://hl7.org/fhir/v3/VaccineManufacturer | 1.0.2 | AVI | Aviron | Aviron | ||
http://hl7.org/fhir/v3/VaccineManufacturer | 1.0.2 | BA | Baxter Healthcare Corporation | Baxter Healthcare Corporation | ||
http://hl7.org/fhir/v3/VaccineManufacturer | 1.0.2 | BAY | Bayer Corporation (includes Miles, Inc. and Cutter Laboratories) | Bayer Corporation (includes Miles, Inc. and Cutter Laboratories) | ||
http://hl7.org/fhir/v3/VaccineManufacturer | 1.0.2 | BP | Berna Products [Inactive - use BPC] | Berna Products [Inactive-use BPC] | ||
http://hl7.org/fhir/v3/VaccineManufacturer | 1.0.2 | BPC | Berna Products Corporation (includes Swiss Serum and Vaccine Institute Berne) | Berna Products Corporation (includes Swiss Serum and Vaccine Institute Berne) | ||
http://hl7.org/fhir/v3/VaccineManufacturer | 1.0.2 | CEN | Centeon L.L.C. (includes Armour Pharmaceutical Company) | Centeon L.L.C. (includes Armour Pharmaceutical Company) | ||
http://hl7.org/fhir/v3/VaccineManufacturer | 1.0.2 | CHI | Chiron Corporation | Chiron Corporation | ||
http://hl7.org/fhir/v3/VaccineManufacturer | 1.0.2 | CON | Connaught [Inactive - use PMC] | Connaught [Inactive-use PMC] | ||
http://hl7.org/fhir/v3/VaccineManufacturer | 1.0.2 | EVN | Evans Medical Limited (an affiliate of Medeva Pharmaceuticals, Inc.) | Evans Medical Limited (an affiliate of Medeva Pharmaceuticals, Inc.) | ||
http://hl7.org/fhir/v3/VaccineManufacturer | 1.0.2 | GRE | Greer Laboratories, Inc. | Greer Laboratories, Inc. | ||
http://hl7.org/fhir/v3/VaccineManufacturer | 1.0.2 | IAG | Immuno International AG | Immuno International AG | ||
http://hl7.org/fhir/v3/VaccineManufacturer | 1.0.2 | IM | Merieux [Inactive - use PMC] | Merieux [Inactive-use PMC] | ||
http://hl7.org/fhir/v3/VaccineManufacturer | 1.0.2 | IUS | Immuno-U.S., Inc. | Immuno-U.S., Inc. | ||
http://hl7.org/fhir/v3/VaccineManufacturer | 1.0.2 | JPN | The Research Foundation for Microbial Diseases of Osaka University (BIKEN) | The Research Foundation for Microbial Diseases of Osaka University (BIKEN) | ||
http://hl7.org/fhir/v3/VaccineManufacturer | 1.0.2 | KGC | Korea Green Cross Corporation | Korea Green Cross Corporation | ||
http://hl7.org/fhir/v3/VaccineManufacturer | 1.0.2 | LED | Lederle [Inactive - use WAL] | Lederle [Inactive-use WAL] | ||
http://hl7.org/fhir/v3/VaccineManufacturer | 1.0.2 | MA | Massachusetts Public Health Biologic Laboratories | Massachusetts Public Health Biologic Laboratories | ||
http://hl7.org/fhir/v3/VaccineManufacturer | 1.0.2 | MED | MedImmune, Inc. | MedImmune, Inc. | ||
http://hl7.org/fhir/v3/VaccineManufacturer | 1.0.2 | MIL | Miles [Inactive - use BAY] | Miles [Inactive-use BAY] | ||
http://hl7.org/fhir/v3/VaccineManufacturer | 1.0.2 | MIP | Bioport Corporation (formerly Michigan Biologic Products Institute) | Bioport Corporation (formerly Michigan Biologic Products Institute) | ||
http://hl7.org/fhir/v3/VaccineManufacturer | 1.0.2 | MSD | Merck and Co., Inc. | Merck & Co., Inc. | ||
http://hl7.org/fhir/v3/VaccineManufacturer | 1.0.2 | NAB | NABI (formerly North American Biologicals, Inc.) | NABI (formerly North American Biologicals, Inc.) | ||
http://hl7.org/fhir/v3/VaccineManufacturer | 1.0.2 | NAV | North American Vaccine, Inc. | North American Vaccine, Inc. | ||
http://hl7.org/fhir/v3/VaccineManufacturer | 1.0.2 | NOV | Novartis Pharmaceutical Corporation (includes Ciba-Geigy Limited and Sandoz Limited) | Novartis Pharmaceutical Corporation (includes Ciba-Geigy Limited and Sandoz Limited) | ||
http://hl7.org/fhir/v3/VaccineManufacturer | 1.0.2 | NYB | New York Blood Center | New York Blood Center | ||
http://hl7.org/fhir/v3/VaccineManufacturer | 1.0.2 | ORT | Ortho Diagnostic Systems, Inc. | Ortho Diagnostic Systems, Inc. | ||
http://hl7.org/fhir/v3/VaccineManufacturer | 1.0.2 | OTC | Organon Teknika Corporation | Organon Teknika Corporation | ||
http://hl7.org/fhir/v3/VaccineManufacturer | 1.0.2 | PD | Parkedale Pharmaceuticals (formerly Parke-Davis) | Parkedale Pharmaceuticals (formerly Parke-Davis) | ||
http://hl7.org/fhir/v3/VaccineManufacturer | 1.0.2 | PMC | Aventis Pasteur Inc. (formerly Pasteur Merieux Connaught; includes Connaught Laboratories and Pasteur Merieux) | Aventis Pasteur Inc. (formerly Pasteur Merieux Connaught; includes Connaught Laboratories and Pasteur Merieux) | ||
http://hl7.org/fhir/v3/VaccineManufacturer | 1.0.2 | PRX | Praxis Biologics [Inactive - use WAL] | Praxis Biologics [Inactive-use WAL] | ||
http://hl7.org/fhir/v3/VaccineManufacturer | 1.0.2 | SCL | Sclavo, Inc. | Sclavo, Inc. | ||
http://hl7.org/fhir/v3/VaccineManufacturer | 1.0.2 | SI | Swiss Serum and Vaccine Inst. [Inactive - use BPC] | Swiss Serum and Vaccine Inst. [Inactive-use BPC] | ||
http://hl7.org/fhir/v3/VaccineManufacturer | 1.0.2 | SKB | SmithKline Beecham | SmithKline Beecham | ||
http://hl7.org/fhir/v3/VaccineManufacturer | 1.0.2 | USA | United States Army Medical Research and Materiel Command | United States Army Medical Research and Materiel Command | ||
http://hl7.org/fhir/v3/VaccineManufacturer | 1.0.2 | WA | Wyeth-Ayerst [Inactive - use WAL] | Wyeth-Ayerst [Inactive-use WAL] | ||
http://hl7.org/fhir/v3/VaccineManufacturer | 1.0.2 | WAL | Wyeth-Ayerst (includes Wyeth-Lederle Vaccines and Pediatrics, Wyeth Laboratories, Lederle Laboratories, and Praxis Biologics) | Wyeth-Ayerst (includes Wyeth-Lederle Vaccines and Pediatrics, Wyeth Laboratories, Lederle Laboratories, and Praxis Biologics) |
Explanation of the columns that may appear on this page:
| Level | A few code lists that FHIR defines are hierarchical - each code is assigned a level. In this scheme, some codes are under other codes, and imply that the code they are under also applies |
| System | The source of the definition of the code (when the value set draws in codes defined elsewhere) |
| Code | The code (used as the code in the resource instance) |
| Display | The display (used in the display element of a Coding). If there is no display, implementers should not simply display the code, but map the concept into their application |
| Definition | An explanation of the meaning of the concept |
| Comments | Additional notes about how to use the code |